Global and China Antidiabetic Thiazolidinediones Market Insights, Forecast to 2027
SKU ID : QYR-18770528 | Publishing Date : 21-Jul-2021 | No. of pages : 140
Detailed TOC of Global and China Antidiabetic Thiazolidinediones Market Insights, Forecast to 2027
1 Study Coverage1.1 Antidiabetic Thiazolidinediones Product Introduction
1.2 Market by Type
1.2.1 Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Type
1.2.2 Rosiglitazone
1.2.3 Pioglitazone
1.3 Market by Application
1.3.1 Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antidiabetic Thiazolidinediones Market Size, Estimates and Forecasts
2.1.1 Global Antidiabetic Thiazolidinediones Revenue 2016-2027
2.1.2 Global Antidiabetic Thiazolidinediones Sales 2016-2027
2.2 Global Antidiabetic Thiazolidinediones, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antidiabetic Thiazolidinediones Historical Market Size by Region (2016-2021)
2.3.1 Global Antidiabetic Thiazolidinediones Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antidiabetic Thiazolidinediones Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antidiabetic Thiazolidinediones Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antidiabetic Thiazolidinediones Sales Forecast by Region (2022-2027)
2.4.2 Global Antidiabetic Thiazolidinediones Revenue Forecast by Region (2022-2027)
3 Global Antidiabetic Thiazolidinediones Competitor Landscape by Players
3.1 Global Top Antidiabetic Thiazolidinediones Manufacturers by Sales
3.1.1 Global Antidiabetic Thiazolidinediones Sales by Manufacturer (2016-2021)
3.1.2 Global Antidiabetic Thiazolidinediones Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antidiabetic Thiazolidinediones Manufacturers by Revenue
3.2.1 Key Antidiabetic Thiazolidinediones Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antidiabetic Thiazolidinediones Revenue by Manufacturers (2016-2021)
3.2.3 Global Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antidiabetic Thiazolidinediones Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antidiabetic Thiazolidinediones Revenue in 2020
3.2.6 Global Antidiabetic Thiazolidinediones Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antidiabetic Thiazolidinediones Price by Manufacturers
3.4 Global Antidiabetic Thiazolidinediones Manufacturing Base Distribution, Product Types
3.4.1 Antidiabetic Thiazolidinediones Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidiabetic Thiazolidinediones Product Type
3.4.3 Date of International Manufacturers Enter into Antidiabetic Thiazolidinediones Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Antidiabetic Thiazolidinediones Market Size by Type (2016-2021)
4.1.1 Global Antidiabetic Thiazolidinediones Sales by Type (2016-2021)
4.1.2 Global Antidiabetic Thiazolidinediones Revenue by Type (2016-2021)
4.1.3 Antidiabetic Thiazolidinediones Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antidiabetic Thiazolidinediones Market Size Forecast by Type (2022-2027)
4.2.1 Global Antidiabetic Thiazolidinediones Sales Forecast by Type (2022-2027)
4.2.2 Global Antidiabetic Thiazolidinediones Revenue Forecast by Type (2022-2027)
4.2.3 Antidiabetic Thiazolidinediones Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Antidiabetic Thiazolidinediones Market Size by Application (2016-2021)
5.1.1 Global Antidiabetic Thiazolidinediones Sales by Application (2016-2021)
5.1.2 Global Antidiabetic Thiazolidinediones Revenue by Application (2016-2021)
5.1.3 Antidiabetic Thiazolidinediones Price by Application (2016-2021)
5.2 Antidiabetic Thiazolidinediones Market Size Forecast by Application (2022-2027)
5.2.1 Global Antidiabetic Thiazolidinediones Sales Forecast by Application (2022-2027)
5.2.2 Global Antidiabetic Thiazolidinediones Revenue Forecast by Application (2022-2027)
5.2.3 Global Antidiabetic Thiazolidinediones Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Antidiabetic Thiazolidinediones Market Size YoY Growth 2016-2027
6.1.1 China Antidiabetic Thiazolidinediones Sales YoY Growth 2016-2027
6.1.2 China Antidiabetic Thiazolidinediones Revenue YoY Growth 2016-2027
6.1.3 China Antidiabetic Thiazolidinediones Market Share in Global Market 2016-2027
6.2 China Antidiabetic Thiazolidinediones Market Size by Players (International and Local Players)
6.2.1 China Top Antidiabetic Thiazolidinediones Players by Sales (2016-2021)
6.2.2 China Top Antidiabetic Thiazolidinediones Players by Revenue (2016-2021)
6.3 China Antidiabetic Thiazolidinediones Historic Market Review by Type (2016-2021)
6.3.1 China Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2021)
6.3.2 China Antidiabetic Thiazolidinediones Revenue Market Share by Type (2016-2021)
6.3.3 China Antidiabetic Thiazolidinediones Price by Type (2016-2021)
6.4 China Antidiabetic Thiazolidinediones Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Antidiabetic Thiazolidinediones Sales Forecast by Type (2022-2027)
6.4.2 China Antidiabetic Thiazolidinediones Revenue Forecast by Type (2022-2027)
6.4.3 China Antidiabetic Thiazolidinediones Price Forecast by Type (2022-2027)
6.5 China Antidiabetic Thiazolidinediones Historic Market Review by Application (2016-2021)
6.5.1 China Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2021)
6.5.2 China Antidiabetic Thiazolidinediones Revenue Market Share by Application (2016-2021)
6.5.3 China Antidiabetic Thiazolidinediones Price by Application (2016-2021)
6.6 China Antidiabetic Thiazolidinediones Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Antidiabetic Thiazolidinediones Sales Forecast by Application (2022-2027)
6.6.2 China Antidiabetic Thiazolidinediones Revenue Forecast by Application (2022-2027)
6.6.3 China Antidiabetic Thiazolidinediones Price Forecast by Application (2022-2027)
7 North America
7.1 North America Antidiabetic Thiazolidinediones Market Size YoY Growth 2016-2027
7.2 North America Antidiabetic Thiazolidinediones Market Facts & Figures by Country
7.2.1 North America Antidiabetic Thiazolidinediones Sales by Country (2016-2021)
7.2.2 North America Antidiabetic Thiazolidinediones Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Antidiabetic Thiazolidinediones Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antidiabetic Thiazolidinediones Market Facts & Figures by Region
8.2.1 Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2016-2021)
8.2.2 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Antidiabetic Thiazolidinediones Market Size YoY Growth 2016-2027
9.2 Europe Antidiabetic Thiazolidinediones Market Facts & Figures by Country
9.2.1 Europe Antidiabetic Thiazolidinediones Sales by Country (2016-2021)
9.2.2 Europe Antidiabetic Thiazolidinediones Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Antidiabetic Thiazolidinediones Market Size YoY Growth 2016-2027
10.2 Latin America Antidiabetic Thiazolidinediones Market Facts & Figures by Country
10.2.1 Latin America Antidiabetic Thiazolidinediones Sales by Country (2016-2021)
10.2.2 Latin America Antidiabetic Thiazolidinediones Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antidiabetic Thiazolidinediones Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antidiabetic Thiazolidinediones Market Facts & Figures by Country
11.2.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Description and Business Overview
12.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Antidiabetic Thiazolidinediones Products Offered
12.1.5 Sanofi Recent Development
12.2 Takeda Pharmaceuticals
12.2.1 Takeda Pharmaceuticals Corporation Information
12.2.2 Takeda Pharmaceuticals Description and Business Overview
12.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Products Offered
12.2.5 Takeda Pharmaceuticals Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Antidiabetic Thiazolidinediones Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Merck & Co.
12.4.1 Merck & Co. Corporation Information
12.4.2 Merck & Co. Description and Business Overview
12.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck & Co. Antidiabetic Thiazolidinediones Products Offered
12.4.5 Merck & Co. Recent Development
12.5 Novo Nordisk
12.5.1 Novo Nordisk Corporation Information
12.5.2 Novo Nordisk Description and Business Overview
12.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novo Nordisk Antidiabetic Thiazolidinediones Products Offered
12.5.5 Novo Nordisk Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Antidiabetic Thiazolidinediones Products Offered
12.7.5 Pfizer Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AstraZeneca Antidiabetic Thiazolidinediones Products Offered
12.8.5 AstraZeneca Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Corporation Information
12.9.2 GlaxoSmithKline Description and Business Overview
12.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.9.4 GlaxoSmithKline Antidiabetic Thiazolidinediones Products Offered
12.9.5 GlaxoSmithKline Recent Development
12.10 Boehringer Ingelheim
12.10.1 Boehringer Ingelheim Corporation Information
12.10.2 Boehringer Ingelheim Description and Business Overview
12.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Boehringer Ingelheim Antidiabetic Thiazolidinediones Products Offered
12.10.5 Boehringer Ingelheim Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Description and Business Overview
12.11.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi Antidiabetic Thiazolidinediones Products Offered
12.11.5 Sanofi Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antidiabetic Thiazolidinediones Industry Trends
13.2 Antidiabetic Thiazolidinediones Market Drivers
13.3 Antidiabetic Thiazolidinediones Market Challenges
13.4 Antidiabetic Thiazolidinediones Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidiabetic Thiazolidinediones Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China Antidiabetic Thiazolidinediones Market Insights, Forecast to 2027
List of TablesTable 1. Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Rosiglitazone
Table 3. Major Manufacturers of Pioglitazone
Table 4. Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 5. Global Antidiabetic Thiazolidinediones Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Antidiabetic Thiazolidinediones Sales by Regions (2016-2021) & (K Pcs)
Table 7. Global Antidiabetic Thiazolidinediones Sales Market Share by Regions (2016-2021)
Table 8. Global Antidiabetic Thiazolidinediones Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Antidiabetic Thiazolidinediones Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Antidiabetic Thiazolidinediones Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Antidiabetic Thiazolidinediones Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Antidiabetic Thiazolidinediones Sales by Manufacturers (2016-2021) (K Pcs)
Table 14. Global Antidiabetic Thiazolidinediones Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Antidiabetic Thiazolidinediones Manufacturers by Revenue (US$ Million) in 2020
Table 16. Antidiabetic Thiazolidinediones Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2016-2021)
Table 18. Global Antidiabetic Thiazolidinediones Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Antidiabetic Thiazolidinediones by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetic Thiazolidinediones as of 2020)
Table 20. Key Manufacturers Antidiabetic Thiazolidinediones Price (2016-2021) (USD/Pcs)
Table 21. Antidiabetic Thiazolidinediones Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antidiabetic Thiazolidinediones Product Type
Table 23. Date of International Manufacturers Enter into Antidiabetic Thiazolidinediones Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Antidiabetic Thiazolidinediones Sales by Type (2016-2021) (K Pcs)
Table 26. Global Antidiabetic Thiazolidinediones Sales Share by Type (2016-2021)
Table 27. Global Antidiabetic Thiazolidinediones Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Antidiabetic Thiazolidinediones Revenue Share by Type (2016-2021)
Table 29. Antidiabetic Thiazolidinediones Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 30. Global Antidiabetic Thiazolidinediones Sales Forecast by Type (2022-2027) & (K Pcs)
Table 31. Global Antidiabetic Thiazolidinediones Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Antidiabetic Thiazolidinediones Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Antidiabetic Thiazolidinediones Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 35. Global Antidiabetic Thiazolidinediones Sales by Application (2016-2021) (K Pcs)
Table 36. Global Antidiabetic Thiazolidinediones Sales Share by Application (2016-2021)
Table 37. Global Antidiabetic Thiazolidinediones Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Antidiabetic Thiazolidinediones Revenue Share by Application (2016-2021)
Table 39. Antidiabetic Thiazolidinediones Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 40. Global Antidiabetic Thiazolidinediones Sales Forecast by Application (2022-2027) & (K Pcs)
Table 41. Global Antidiabetic Thiazolidinediones Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Antidiabetic Thiazolidinediones Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Antidiabetic Thiazolidinediones Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 45. China Antidiabetic Thiazolidinediones Sales (K Pcs) of Key Companies (2016-2021)
Table 46. China Antidiabetic Thiazolidinediones Sales Share by Company (2016-2021)
Table 47. China Antidiabetic Thiazolidinediones Revenue (US$ Million) by Company (2016-2021)
Table 48. China Antidiabetic Thiazolidinediones Revenue Share by Company (2016-2021)
Table 49. China Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2016-2021)
Table 50. China Antidiabetic Thiazolidinediones Sales Share by Type (2016-2021)
Table 51. China Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Antidiabetic Thiazolidinediones Price (USD/Pcs) by Type (2016-2021)
Table 53. China Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2022-2027)
Table 54. China Antidiabetic Thiazolidinediones Sales Share by Type (2022-2027)
Table 55. China Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Antidiabetic Thiazolidinediones Revenue Share by Type (2022-2027)
Table 57. China Antidiabetic Thiazolidinediones Price (USD/Pcs) by Type (2022-2027)
Table 58. China Antidiabetic Thiazolidinediones Sales (K Pcs) by Application (2016-2021)
Table 59. China Antidiabetic Thiazolidinediones Sales Share by Application (2016-2021)
Table 60. China Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Antidiabetic Thiazolidinediones Price (USD/Pcs) by Application (2016-2021)
Table 62. China Antidiabetic Thiazolidinediones Sales (K Pcs) by Application (2022-2027)
Table 63. China Antidiabetic Thiazolidinediones Sales Share by Application (2022-2027)
Table 64. China Antidiabetic Thiazolidinediones Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Antidiabetic Thiazolidinediones Revenue Share by Application (2022-2027)
Table 66. China Antidiabetic Thiazolidinediones Price (USD/Pcs) by Application (2022-2027)
Table 67. North America Antidiabetic Thiazolidinediones Sales by Country (2016-2021) & (K Pcs)
Table 68. North America Antidiabetic Thiazolidinediones Sales Market Share by Country (2016-2021)
Table 69. North America Antidiabetic Thiazolidinediones Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Antidiabetic Thiazolidinediones Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2016-2021) & (K Pcs)
Table 72. Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Antidiabetic Thiazolidinediones Revenue Market Share by Region (2016-2021)
Table 75. Europe Antidiabetic Thiazolidinediones Sales by Country (2016-2021) & (K Pcs)
Table 76. Europe Antidiabetic Thiazolidinediones Sales Market Share by Country (2016-2021)
Table 77. Europe Antidiabetic Thiazolidinediones Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Antidiabetic Thiazolidinediones Revenue Market Share by Country (2016-2021)
Table 79. Latin America Antidiabetic Thiazolidinediones Sales by Country (2016-2021) & (K Pcs)
Table 80. Latin America Antidiabetic Thiazolidinediones Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Antidiabetic Thiazolidinediones Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Antidiabetic Thiazolidinediones Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2016-2021) & (K Pcs)
Table 84. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Antidiabetic Thiazolidinediones Revenue Market Share by Country (2016-2021)
Table 87. Sanofi Corporation Information
Table 88. Sanofi Description and Business Overview
Table 89. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 90. Sanofi Antidiabetic Thiazolidinediones Product
Table 91. Sanofi Recent Development
Table 92. Takeda Pharmaceuticals Corporation Information
Table 93. Takeda Pharmaceuticals Description and Business Overview
Table 94. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 95. Takeda Pharmaceuticals Product
Table 96. Takeda Pharmaceuticals Recent Development
Table 97. Eli Lilly Corporation Information
Table 98. Eli Lilly Description and Business Overview
Table 99. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 100. Eli Lilly Product
Table 101. Eli Lilly Recent Development
Table 102. Merck & Co. Corporation Information
Table 103. Merck & Co. Description and Business Overview
Table 104. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 105. Merck & Co. Product
Table 106. Merck & Co. Recent Development
Table 107. Novo Nordisk Corporation Information
Table 108. Novo Nordisk Description and Business Overview
Table 109. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 110. Novo Nordisk Product
Table 111. Novo Nordisk Recent Development
Table 112. Bristol-Myers Squibb Corporation Information
Table 113. Bristol-Myers Squibb Description and Business Overview
Table 114. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Bristol-Myers Squibb Product
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Pfizer Corporation Information
Table 118. Pfizer Description and Business Overview
Table 119. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. Pfizer Product
Table 121. Pfizer Recent Development
Table 122. AstraZeneca Corporation Information
Table 123. AstraZeneca Description and Business Overview
Table 124. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. AstraZeneca Product
Table 126. AstraZeneca Recent Development
Table 127. GlaxoSmithKline Corporation Information
Table 128. GlaxoSmithKline Description and Business Overview
Table 129. GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. GlaxoSmithKline Product
Table 131. GlaxoSmithKline Recent Development
Table 132. Boehringer Ingelheim Corporation Information
Table 133. Boehringer Ingelheim Description and Business Overview
Table 134. Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. Boehringer Ingelheim Product
Table 136. Boehringer Ingelheim Recent Development
Table 137. Antidiabetic Thiazolidinediones Market Trends
Table 138. Antidiabetic Thiazolidinediones Market Drivers
Table 139. Antidiabetic Thiazolidinediones Market Challenges
Table 140. Antidiabetic Thiazolidinediones Market Restraints
Table 141. Antidiabetic Thiazolidinediones Customers List
Table 142. Antidiabetic Thiazolidinediones Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Antidiabetic Thiazolidinediones Product Picture
Figure 2. Global Antidiabetic Thiazolidinediones Sales Market Share by Type in 2020 & 2027
Figure 3. Rosiglitazone Product Picture
Figure 4. Pioglitazone Product Picture
Figure 5. Global Antidiabetic Thiazolidinediones Sales Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Antidiabetic Thiazolidinediones Report Years Considered
Figure 10. Global Antidiabetic Thiazolidinediones Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Antidiabetic Thiazolidinediones Market Size 2016-2027 (US$ Million)
Figure 12. Global Antidiabetic Thiazolidinediones Sales 2016-2027 (K Pcs)
Figure 13. Global Antidiabetic Thiazolidinediones Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Antidiabetic Thiazolidinediones Sales Market Share by Region (2016-2021)
Figure 15. Global Antidiabetic Thiazolidinediones Sales Market Share by Region in 2020
Figure 16. Global Antidiabetic Thiazolidinediones Revenue Market Share by Region (2016-2021)
Figure 17. Global Antidiabetic Thiazolidinediones Revenue Market Share by Region in 2020
Figure 18. Global Antidiabetic Thiazolidinediones Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Antidiabetic Thiazolidinediones Revenue in 2020
Figure 20. Antidiabetic Thiazolidinediones Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2021)
Figure 22. Global Antidiabetic Thiazolidinediones Sales Market Share by Type in 2020
Figure 23. Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2016-2021)
Figure 24. Global Antidiabetic Thiazolidinediones Revenue Market Share by Type in 2020
Figure 25. Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2021)
Figure 26. Global Antidiabetic Thiazolidinediones Sales Market Share by Application in 2020
Figure 27. Global Antidiabetic Thiazolidinediones Revenue Market Share by Application (2016-2021)
Figure 28. Global Antidiabetic Thiazolidinediones Revenue Market Share by Application in 2020
Figure 29. China Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2027 (K Pcs)
Figure 30. China Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Antidiabetic Thiazolidinediones Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Antidiabetic Thiazolidinediones Players Market Share by Revenue in Antidiabetic Thiazolidinediones in 2020
Figure 33. China Antidiabetic Thiazolidinediones Revenue Share by Type (2016-2021)
Figure 34. China Antidiabetic Thiazolidinediones Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Antidiabetic Thiazolidinediones Revenue Share by Application (2016-2021)
Figure 36. China Antidiabetic Thiazolidinediones Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2021 (K Pcs)
Figure 38. North America Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Antidiabetic Thiazolidinediones Sales Market Share by Country in 2020
Figure 40. North America Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2020
Figure 41. U.S. Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 42. U.S. Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 44. Canada Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2021 (K Pcs)
Figure 46. Europe Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Antidiabetic Thiazolidinediones Sales Market Share by Country in 2020
Figure 48. Europe Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2020
Figure 49. Germany Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 50. Germany Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 52. France Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. U.K. Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. Italy Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. Russia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2021 (K Pcs)
Figure 60. Asia Pacific Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Region in 2020
Figure 62. Asia Pacific Antidiabetic Thiazolidinediones Revenue Market Share by Region in 2020
Figure 63. China Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 64. China Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 66. Japan Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. South Korea Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. India Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. Australia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. China Taiwan Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Indonesia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Thailand Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Malaysia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2021 (K Pcs)
Figure 82. Latin America Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Antidiabetic Thiazolidinediones Sales Market Share by Country in 2020
Figure 84. Latin America Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2020
Figure 85. Mexico Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Mexico Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Brazil Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 90. Argentina Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2021 (K Pcs)
Figure 92. Middle East and Africa Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2020
Figure 95. Turkey Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Turkey Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 98. Saudi Arabia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2021) (K Pcs)
Figure 100. UAE Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Antidiabetic Thiazolidinediones Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
Keyplayers in Global and China Antidiabetic Thiazolidinediones Market Insights, Forecast to 2027
SanofiTakeda Pharmaceuticals
Eli Lilly
Merck & Co.
Novo Nordisk
Bristol-Myers Squibb
Pfizer
AstraZeneca
GlaxoSmithKline
Boehringer Ingelheim